TPST
Tempest Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.26
-0.03 ▼ -1.31%
🌙 3월 13일 7:50 PM ET (한국 3/14 08:50)
$2.27
+0.01 ▲ +0.44%
| Index | - | P/E | - | EPS (ttm) | -10.1 | Insider Own | 38.18% | Shs Outstand | 0.01B | Perf Week | -2.16% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | 54.75% | Insider Trans | - | Shs Float | 0.01B | Perf Month | -3% |
| Enterprise Value | 0.03B | PEG | - | EPS next Q | -0.62 | Inst Own | 3.59% | Short Float | 2.04% | Perf Quarter | -28.25% |
| Income | -0.04B | P/S | - | EPS this Y | 68.72% | Inst Trans | 12.74% | Short Ratio | 1.62 | Perf Half Y | -78.9% |
| Sales | 0.00B | P/B | 1.58 | EPS next 5Y | 51.1% | ROA | -141.49% | Short Interest | 0.17M | Perf YTD | -21.25% |
| Book/sh | 1.43 | P/C | 4.06 | EPS past 3/5Y | 41.44% 50.16% | ROE | -405.03% | 52W High | -81.52% ($12.23) | Perf Year | -79.16% |
| Cash/sh | 0.56 | P/FCF | - | Sales past 3/5Y | - | ROIC | -265.02% | 52W Low | 6.6% ($2.12) | Perf 3Y | -84.75% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 49.43% | Gross Margin | - | Volatility(W/M) | 4.67% 5.45% | Perf 5Y | -99.46% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.15 | Perf 10Y | -99.99% |
| Dividend Ex-Date | - | Quick Ratio | 2.3 | EPS Q/Q | 85.13% | Profit Margin | - | RSI (14) | 39.7 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.3 | Sales Q/Q | - | SMA20 | -3.58% ($2.34) | Beta | -2.19 | Target Price | $11 |
| Payout | - | Debt/Eq | 1.32 | Earnings | 11000000 | SMA50 | -11.08% ($2.54) | Rel Volume | 0.44 | Prev Close | $2.29 |
| Employees | 25 | LT Debt/Eq | 1.14 | EPS/Sales Surpr. | - | SMA200 | -65.12% ($6.48) | Avg Volume(3M) | 0.11M | Price | $2.26 |
| IPO | 2012/11/12 | Option/Short | No/Yes | Trades | 307 | Volume | 46,832 | Change | -1.31% |
뉴스 로딩 중...